Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 29;8(1):1789.
doi: 10.1038/s41598-018-19957-z.

Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens

Affiliations

Rheumatoid arthritis patient antibodies highly recognize IL-2 in the immune response pathway involving IRF5 and EBV antigens

Marco Bo et al. Sci Rep. .

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by a progressive joint damage due to largely unknown environmental factors acting in concert with risk alleles conferring genetic susceptibility. A major role has been attributed to viral infections that include past contacts with Epstein-Barr virus (EBV) and, more recently, to non-protein coding sequences of human endogenous retrovirus K (HERV-K) integrated in the human genome. Molecular mimicry between viral and self proteins is supposed to cause the loss of immune tolerance in predisposed hosts. There are evidences that anti-IL-2 antibodies (Abs) are present in subjects affected by autoimmune diseases and may be responsible for alterations in regulatory T cell responses. In this study, we evaluated the levels of Abs against IL-2, viral epitopes and interferon regulatory factor 5 (IRF5) in 140 RA patients and 137 healthy controls (HCs). Ab reactivity reached the highest levels for IRF5, EBV and IL-2 (56%, 44% and 39%, respectively) in RA with significantly lower values among HCs (7-9%, p < 0.0001), which suggests a possible cross-reaction between IRF5/EBV homologous antigens and shifts in T cell balance disrupted by anti-IL-2 Abs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
ELISA-based analysis of Abs reactivity against human, viral and MAP-derived peptides in RA, NMOSD and HCs. The sera were tested against plate-coated IL-26–20KK (B), IL-256–70 (A), IRF5424–434 (C), BOLF1305–320 (D), Herv-Kenv19–37 (E) and MAP_402718–32 (F) peptides. Bars represent the median ± interquartile range. Thresholds for Abs positivity are indicated by dashed lines. Percentages of Abs prevalence respective to each group, AUC and P-values are indicated above the distributions.
Figure 2
Figure 2
Abs reactivity against the antigenic peptide derived from H. pylori in RA patients and HCs. Bars represent mean value ± interquartile range, while dashed lines indicate the positivity threshold. Despite sequence homology to human ZnT8 protein fragment, no significant differences in Abs levels were detected.
Figure 3
Figure 3
Scatter plots showing correlations between Abs titers in RA patients. Pairwise distributions are classified for homologous peptides (A), IL-26–20KK (B) and IL-256–70 (C). Each dot correspond to OD values obtained for a single patient.

References

    1. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423:356–361. doi: 10.1038/nature01661. - DOI - PubMed
    1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365:2205–2219. doi: 10.1056/NEJMra1004965. - DOI - PubMed
    1. Ollier W. Rheumatoid arthritis and Epstein-Barr virus: a case of living with the enemy? Ann Rheum Dis. 2000;59:497–499. doi: 10.1136/ard.59.7.497. - DOI - PMC - PubMed
    1. Hadinoto V, et al. The dynamics of EBV shedding implicate a central role for epithelial cells in amplifying viral output. PloS Pathog. 2009;5(7):e1000496. doi: 10.1371/journal.ppat.1000496. - DOI - PMC - PubMed
    1. Adtani P, Malathi N. Epstein-Barr virus and its association with rheumatoid arthritis and oral lichen planus. J Oral Maxillofac Pathol. 2015;19(3):282–5. doi: 10.4103/0973-029X.174643. - DOI - PMC - PubMed